MAPK8 and metabolic dysfunction-associated steatotic liver disease: These results indicate that JGXZ may alleviate the inflammatory response to NAFLD by downregulating NF-κB p65 phosphorylation, JNK1/2, and C-JUN levels in the liver tissues and reducing inflammatory cytokine levels.